img

Global Rapid Antigen Testing Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Rapid Antigen Testing Market Research Report 2024

According to MRAResearch’s new survey, global Rapid Antigen Testing market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Rapid Antigen Testing market research.
Key companies engaged in the Rapid Antigen Testing industry include Abbott Laboratories, F. Hoffmann-La Roche, Oxford BioMedica, Affinity Biologicals, Epitope Diagnostics, Sino Biological, R-Biopharma, Cell Biolabs and Thermo Fisher Scientific, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Rapid Antigen Testing were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Rapid Antigen Testing market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Rapid Antigen Testing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Abbott Laboratories
F. Hoffmann-La Roche
Oxford BioMedica
Affinity Biologicals
Epitope Diagnostics
Sino Biological
R-Biopharma
Cell Biolabs
Thermo Fisher Scientific
Bio-Rad Laboratories
Segment by Type
Immunosorbent Assay
Enzyme-linked Immunosorbent
Precipitation Reaction
Radioimmunoassay
Agglutination Reaction
Complement Fixatio

Segment by Application


Hospitals
Specialty Clinics
Diagnostic Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Rapid Antigen Testing report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Rapid Antigen Testing Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Immunosorbent Assay
1.2.3 Enzyme-linked Immunosorbent
1.2.4 Precipitation Reaction
1.2.5 Radioimmunoassay
1.2.6 Agglutination Reaction
1.2.7 Complement Fixatio
1.3 Market by Application
1.3.1 Global Rapid Antigen Testing Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Diagnostic Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Rapid Antigen Testing Market Perspective (2018-2033)
2.2 Rapid Antigen Testing Growth Trends by Region
2.2.1 Global Rapid Antigen Testing Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Rapid Antigen Testing Historic Market Size by Region (2018-2023)
2.2.3 Rapid Antigen Testing Forecasted Market Size by Region (2024-2033)
2.3 Rapid Antigen Testing Market Dynamics
2.3.1 Rapid Antigen Testing Industry Trends
2.3.2 Rapid Antigen Testing Market Drivers
2.3.3 Rapid Antigen Testing Market Challenges
2.3.4 Rapid Antigen Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Rapid Antigen Testing Players by Revenue
3.1.1 Global Top Rapid Antigen Testing Players by Revenue (2018-2023)
3.1.2 Global Rapid Antigen Testing Revenue Market Share by Players (2018-2023)
3.2 Global Rapid Antigen Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Rapid Antigen Testing Revenue
3.4 Global Rapid Antigen Testing Market Concentration Ratio
3.4.1 Global Rapid Antigen Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Rapid Antigen Testing Revenue in 2022
3.5 Rapid Antigen Testing Key Players Head office and Area Served
3.6 Key Players Rapid Antigen Testing Product Solution and Service
3.7 Date of Enter into Rapid Antigen Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Rapid Antigen Testing Breakdown Data by Type
4.1 Global Rapid Antigen Testing Historic Market Size by Type (2018-2023)
4.2 Global Rapid Antigen Testing Forecasted Market Size by Type (2024-2033)
5 Rapid Antigen Testing Breakdown Data by Application
5.1 Global Rapid Antigen Testing Historic Market Size by Application (2018-2023)
5.2 Global Rapid Antigen Testing Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Rapid Antigen Testing Market Size (2018-2033)
6.2 North America Rapid Antigen Testing Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Rapid Antigen Testing Market Size by Country (2018-2023)
6.4 North America Rapid Antigen Testing Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Rapid Antigen Testing Market Size (2018-2033)
7.2 Europe Rapid Antigen Testing Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Rapid Antigen Testing Market Size by Country (2018-2023)
7.4 Europe Rapid Antigen Testing Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Rapid Antigen Testing Market Size (2018-2033)
8.2 Asia-Pacific Rapid Antigen Testing Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Rapid Antigen Testing Market Size by Region (2018-2023)
8.4 Asia-Pacific Rapid Antigen Testing Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Rapid Antigen Testing Market Size (2018-2033)
9.2 Latin America Rapid Antigen Testing Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Rapid Antigen Testing Market Size by Country (2018-2023)
9.4 Latin America Rapid Antigen Testing Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Rapid Antigen Testing Market Size (2018-2033)
10.2 Middle East & Africa Rapid Antigen Testing Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Rapid Antigen Testing Market Size by Country (2018-2023)
10.4 Middle East & Africa Rapid Antigen Testing Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Rapid Antigen Testing Introduction
11.1.4 Abbott Laboratories Revenue in Rapid Antigen Testing Business (2018-2023)
11.1.5 Abbott Laboratories Recent Development
11.2 F. Hoffmann-La Roche
11.2.1 F. Hoffmann-La Roche Company Detail
11.2.2 F. Hoffmann-La Roche Business Overview
11.2.3 F. Hoffmann-La Roche Rapid Antigen Testing Introduction
11.2.4 F. Hoffmann-La Roche Revenue in Rapid Antigen Testing Business (2018-2023)
11.2.5 F. Hoffmann-La Roche Recent Development
11.3 Oxford BioMedica
11.3.1 Oxford BioMedica Company Detail
11.3.2 Oxford BioMedica Business Overview
11.3.3 Oxford BioMedica Rapid Antigen Testing Introduction
11.3.4 Oxford BioMedica Revenue in Rapid Antigen Testing Business (2018-2023)
11.3.5 Oxford BioMedica Recent Development
11.4 Affinity Biologicals
11.4.1 Affinity Biologicals Company Detail
11.4.2 Affinity Biologicals Business Overview
11.4.3 Affinity Biologicals Rapid Antigen Testing Introduction
11.4.4 Affinity Biologicals Revenue in Rapid Antigen Testing Business (2018-2023)
11.4.5 Affinity Biologicals Recent Development
11.5 Epitope Diagnostics
11.5.1 Epitope Diagnostics Company Detail
11.5.2 Epitope Diagnostics Business Overview
11.5.3 Epitope Diagnostics Rapid Antigen Testing Introduction
11.5.4 Epitope Diagnostics Revenue in Rapid Antigen Testing Business (2018-2023)
11.5.5 Epitope Diagnostics Recent Development
11.6 Sino Biological
11.6.1 Sino Biological Company Detail
11.6.2 Sino Biological Business Overview
11.6.3 Sino Biological Rapid Antigen Testing Introduction
11.6.4 Sino Biological Revenue in Rapid Antigen Testing Business (2018-2023)
11.6.5 Sino Biological Recent Development
11.7 R-Biopharma
11.7.1 R-Biopharma Company Detail
11.7.2 R-Biopharma Business Overview
11.7.3 R-Biopharma Rapid Antigen Testing Introduction
11.7.4 R-Biopharma Revenue in Rapid Antigen Testing Business (2018-2023)
11.7.5 R-Biopharma Recent Development
11.8 Cell Biolabs
11.8.1 Cell Biolabs Company Detail
11.8.2 Cell Biolabs Business Overview
11.8.3 Cell Biolabs Rapid Antigen Testing Introduction
11.8.4 Cell Biolabs Revenue in Rapid Antigen Testing Business (2018-2023)
11.8.5 Cell Biolabs Recent Development
11.9 Thermo Fisher Scientific
11.9.1 Thermo Fisher Scientific Company Detail
11.9.2 Thermo Fisher Scientific Business Overview
11.9.3 Thermo Fisher Scientific Rapid Antigen Testing Introduction
11.9.4 Thermo Fisher Scientific Revenue in Rapid Antigen Testing Business (2018-2023)
11.9.5 Thermo Fisher Scientific Recent Development
11.10 Bio-Rad Laboratories
11.10.1 Bio-Rad Laboratories Company Detail
11.10.2 Bio-Rad Laboratories Business Overview
11.10.3 Bio-Rad Laboratories Rapid Antigen Testing Introduction
11.10.4 Bio-Rad Laboratories Revenue in Rapid Antigen Testing Business (2018-2023)
11.10.5 Bio-Rad Laboratories Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Rapid Antigen Testing Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Immunosorbent Assay
Table 3. Key Players of Enzyme-linked Immunosorbent
Table 4. Key Players of Precipitation Reaction
Table 5. Key Players of Radioimmunoassay
Table 6. Key Players of Agglutination Reaction
Table 7. Key Players of Complement Fixatio
Table 8. Global Rapid Antigen Testing Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 9. Global Rapid Antigen Testing Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 10. Global Rapid Antigen Testing Market Size by Region (2018-2023) & (US$ Million)
Table 11. Global Rapid Antigen Testing Market Share by Region (2018-2023)
Table 12. Global Rapid Antigen Testing Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 13. Global Rapid Antigen Testing Market Share by Region (2024-2033)
Table 14. Rapid Antigen Testing Market Trends
Table 15. Rapid Antigen Testing Market Drivers
Table 16. Rapid Antigen Testing Market Challenges
Table 17. Rapid Antigen Testing Market Restraints
Table 18. Global Rapid Antigen Testing Revenue by Players (2018-2023) & (US$ Million)
Table 19. Global Rapid Antigen Testing Market Share by Players (2018-2023)
Table 20. Global Top Rapid Antigen Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rapid Antigen Testing as of 2022)
Table 21. Ranking of Global Top Rapid Antigen Testing Companies by Revenue (US$ Million) in 2022
Table 22. Global 5 Largest Players Market Share by Rapid Antigen Testing Revenue (CR5 and HHI) & (2018-2023)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Rapid Antigen Testing Product Solution and Service
Table 25. Date of Enter into Rapid Antigen Testing Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Rapid Antigen Testing Market Size by Type (2018-2023) & (US$ Million)
Table 28. Global Rapid Antigen Testing Revenue Market Share by Type (2018-2023)
Table 29. Global Rapid Antigen Testing Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 30. Global Rapid Antigen Testing Revenue Market Share by Type (2024-2033)
Table 31. Global Rapid Antigen Testing Market Size by Application (2018-2023) & (US$ Million)
Table 32. Global Rapid Antigen Testing Revenue Market Share by Application (2018-2023)
Table 33. Global Rapid Antigen Testing Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 34. Global Rapid Antigen Testing Revenue Market Share by Application (2024-2033)
Table 35. North America Rapid Antigen Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. North America Rapid Antigen Testing Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Rapid Antigen Testing Market Size by Country (2024-2033) & (US$ Million)
Table 38. Europe Rapid Antigen Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 39. Europe Rapid Antigen Testing Market Size by Country (2018-2023) & (US$ Million)
Table 40. Europe Rapid Antigen Testing Market Size by Country (2024-2033) & (US$ Million)
Table 41. Asia-Pacific Rapid Antigen Testing Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 42. Asia-Pacific Rapid Antigen Testing Market Size by Region (2018-2023) & (US$ Million)
Table 43. Asia-Pacific Rapid Antigen Testing Market Size by Region (2024-2033) & (US$ Million)
Table 44. Latin America Rapid Antigen Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Latin America Rapid Antigen Testing Market Size by Country (2018-2023) & (US$ Million)
Table 46. Latin America Rapid Antigen Testing Market Size by Country (2024-2033) & (US$ Million)
Table 47. Middle East & Africa Rapid Antigen Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 48. Middle East & Africa Rapid Antigen Testing Market Size by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Rapid Antigen Testing Market Size by Country (2024-2033) & (US$ Million)
Table 50. Abbott Laboratories Company Detail
Table 51. Abbott Laboratories Business Overview
Table 52. Abbott Laboratories Rapid Antigen Testing Product
Table 53. Abbott Laboratories Revenue in Rapid Antigen Testing Business (2018-2023) & (US$ Million)
Table 54. Abbott Laboratories Recent Development
Table 55. F. Hoffmann-La Roche Company Detail
Table 56. F. Hoffmann-La Roche Business Overview
Table 57. F. Hoffmann-La Roche Rapid Antigen Testing Product
Table 58. F. Hoffmann-La Roche Revenue in Rapid Antigen Testing Business (2018-2023) & (US$ Million)
Table 59. F. Hoffmann-La Roche Recent Development
Table 60. Oxford BioMedica Company Detail
Table 61. Oxford BioMedica Business Overview
Table 62. Oxford BioMedica Rapid Antigen Testing Product
Table 63. Oxford BioMedica Revenue in Rapid Antigen Testing Business (2018-2023) & (US$ Million)
Table 64. Oxford BioMedica Recent Development
Table 65. Affinity Biologicals Company Detail
Table 66. Affinity Biologicals Business Overview
Table 67. Affinity Biologicals Rapid Antigen Testing Product
Table 68. Affinity Biologicals Revenue in Rapid Antigen Testing Business (2018-2023) & (US$ Million)
Table 69. Affinity Biologicals Recent Development
Table 70. Epitope Diagnostics Company Detail
Table 71. Epitope Diagnostics Business Overview
Table 72. Epitope Diagnostics Rapid Antigen Testing Product
Table 73. Epitope Diagnostics Revenue in Rapid Antigen Testing Business (2018-2023) & (US$ Million)
Table 74. Epitope Diagnostics Recent Development
Table 75. Sino Biological Company Detail
Table 76. Sino Biological Business Overview
Table 77. Sino Biological Rapid Antigen Testing Product
Table 78. Sino Biological Revenue in Rapid Antigen Testing Business (2018-2023) & (US$ Million)
Table 79. Sino Biological Recent Development
Table 80. R-Biopharma Company Detail
Table 81. R-Biopharma Business Overview
Table 82. R-Biopharma Rapid Antigen Testing Product
Table 83. R-Biopharma Revenue in Rapid Antigen Testing Business (2018-2023) & (US$ Million)
Table 84. R-Biopharma Recent Development
Table 85. Cell Biolabs Company Detail
Table 86. Cell Biolabs Business Overview
Table 87. Cell Biolabs Rapid Antigen Testing Product
Table 88. Cell Biolabs Revenue in Rapid Antigen Testing Business (2018-2023) & (US$ Million)
Table 89. Cell Biolabs Recent Development
Table 90. Thermo Fisher Scientific Company Detail
Table 91. Thermo Fisher Scientific Business Overview
Table 92. Thermo Fisher Scientific Rapid Antigen Testing Product
Table 93. Thermo Fisher Scientific Revenue in Rapid Antigen Testing Business (2018-2023) & (US$ Million)
Table 94. Thermo Fisher Scientific Recent Development
Table 95. Bio-Rad Laboratories Company Detail
Table 96. Bio-Rad Laboratories Business Overview
Table 97. Bio-Rad Laboratories Rapid Antigen Testing Product
Table 98. Bio-Rad Laboratories Revenue in Rapid Antigen Testing Business (2018-2023) & (US$ Million)
Table 99. Bio-Rad Laboratories Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Rapid Antigen Testing Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Rapid Antigen Testing Market Share by Type: 2022 VS 2033
Figure 3. Immunosorbent Assay Features
Figure 4. Enzyme-linked Immunosorbent Features
Figure 5. Precipitation Reaction Features
Figure 6. Radioimmunoassay Features
Figure 7. Agglutination Reaction Features
Figure 8. Complement Fixatio Features
Figure 9. Global Rapid Antigen Testing Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 10. Global Rapid Antigen Testing Market Share by Application: 2022 VS 2033
Figure 11. Hospitals Case Studies
Figure 12. Specialty Clinics Case Studies
Figure 13. Diagnostic Centers Case Studies
Figure 14. Others Case Studies
Figure 15. Rapid Antigen Testing Report Years Considered
Figure 16. Global Rapid Antigen Testing Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 17. Global Rapid Antigen Testing Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 18. Global Rapid Antigen Testing Market Share by Region: 2022 VS 2033
Figure 19. Global Rapid Antigen Testing Market Share by Players in 2022
Figure 20. Global Top Rapid Antigen Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rapid Antigen Testing as of 2022)
Figure 21. The Top 10 and 5 Players Market Share by Rapid Antigen Testing Revenue in 2022
Figure 22. North America Rapid Antigen Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. North America Rapid Antigen Testing Market Share by Country (2018-2033)
Figure 24. United States Rapid Antigen Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Canada Rapid Antigen Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Europe Rapid Antigen Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Europe Rapid Antigen Testing Market Share by Country (2018-2033)
Figure 28. Germany Rapid Antigen Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. France Rapid Antigen Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. U.K. Rapid Antigen Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Italy Rapid Antigen Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Russia Rapid Antigen Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Nordic Countries Rapid Antigen Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Asia-Pacific Rapid Antigen Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Asia-Pacific Rapid Antigen Testing Market Share by Region (2018-2033)
Figure 36. China Rapid Antigen Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Japan Rapid Antigen Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. South Korea Rapid Antigen Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Southeast Asia Rapid Antigen Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. India Rapid Antigen Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Australia Rapid Antigen Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Latin America Rapid Antigen Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Latin America Rapid Antigen Testing Market Share by Country (2018-2033)
Figure 44. Mexico Rapid Antigen Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Brazil Rapid Antigen Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Middle East & Africa Rapid Antigen Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Middle East & Africa Rapid Antigen Testing Market Share by Country (2018-2033)
Figure 48. Turkey Rapid Antigen Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Saudi Arabia Rapid Antigen Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 50. Abbott Laboratories Revenue Growth Rate in Rapid Antigen Testing Business (2018-2023)
Figure 51. F. Hoffmann-La Roche Revenue Growth Rate in Rapid Antigen Testing Business (2018-2023)
Figure 52. Oxford BioMedica Revenue Growth Rate in Rapid Antigen Testing Business (2018-2023)
Figure 53. Affinity Biologicals Revenue Growth Rate in Rapid Antigen Testing Business (2018-2023)
Figure 54. Epitope Diagnostics Revenue Growth Rate in Rapid Antigen Testing Business (2018-2023)
Figure 55. Sino Biological Revenue Growth Rate in Rapid Antigen Testing Business (2018-2023)
Figure 56. R-Biopharma Revenue Growth Rate in Rapid Antigen Testing Business (2018-2023)
Figure 57. Cell Biolabs Revenue Growth Rate in Rapid Antigen Testing Business (2018-2023)
Figure 58. Thermo Fisher Scientific Revenue Growth Rate in Rapid Antigen Testing Business (2018-2023)
Figure 59. Bio-Rad Laboratories Revenue Growth Rate in Rapid Antigen Testing Business (2018-2023)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed